Abstract
PURPOSE: Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma, PHAROS, is a multi-center, prospective, observational study of scleroderma patients who are at high risk for PAH or who have definite PH by right heart catheterization. Purpose: To describe the relationship and predictive value of scleroderma specific auto-antibodies in this population.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have